Ionis Pharmaceuticals's total assets for Q2 2024 were $2.69B, a decrease of -2.63% from the previous quarter. IONS total liabilities were $1.24B for the fiscal quarter, a -3.24% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.